[The clinical manifestations and the plasma levels of fibronectin and fibrin-fibrinogen degradation products in different morphological forms of chronic hepatitis].
The paper provides the results of studying the clinical disease manifestations, the plasma content of fibronectin and fibrin and fibrinogen degradation products in patients with chronic hepatitis (CH). It is shown that they are determined not only by the morphological form of CH but also by the structure of inflammatory infiltrates in liver tissue.
Malaia
L T
LT
Iabluchanskiĭ
N I
NI
Panchuk
S N
SN
Babak
O Ia
OIa
D000328:Adult; D001706:Biopsy; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D005353:Fibronectins / Q000097:blood*; D006521:Hepatitis, Chronic / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D008099:Liver / Q000473:pathology; D008297:Male; D008875:Middle Aged
D005338:Fibrin Fibrinogen Degradation Products; D005353:Fibronectins
Klinicheskie proiavleniia, soderzhanie fibronektina, produktov degradatsii fibrina i fibrinogena plazmy pri razlichnykh morfologicheskikh formakh khronicheskikh gepatitov.